digiMedical Solutions, Inc. Rolls Out Easy-to-Use, Next Generation Prescription Software and Call Center Services for Cardiologist Dr. Barry Schiff
digiMedical Solutions, Inc. (PINKSHEETS: DGMS) today announced that the Company has rolled out its next generation prescription handling software and unique prescription reauthorization call center services for cardiologist Dr. Barry Schiff of the University Heart Institute in Pembroke Pines, Florida.
digiMedical’s Next Generation Prescription Handling Software
digiMedical provides an easy-to-use, digital prescription toolset to both doctors and pharmacies to streamline the prescription process. Doctors use a handheld device or desktop computer to easily and quickly ‘write’ a prescription, which is then securely transmitted directly to the pharmacy of the patient’s choosing. The medication and pharmacy choices are all preloaded in the system, customized to the doctor’s location and needs. The software meets all HIPAA and DEA requirements and helps protect both the doctor and pharmacist from errors caused by difficult-to-read handwritten prescriptions and the risk of illegally duplicated prescriptions and fraudulent prescriptions.
Pharmacies that also use the digiMedical software will receive the prescription quickly and securely, with all pertinent patient information, allowing the pharmacy to pre-fill the prescription prior to the patient’s arrival at the pharmacy and better track and forecast pharmaceutical supply needs. Other pharmacies, not yet using digiMedical software, receive the prescription via secure fax.
To learn more about the software’s robust features, please contact the company at firstname.lastname@example.org or 1-877-450-8181. The software is compatible with most medical office software and is easy to install and learn to use.
digiMedical’s Prescription reauthorization Call Center Services
Additionally, digiMedical manages prescription refills for physicians’ offices and clinics through the Company’s unique digiReauth software and call center services. Doctors can significantly reduce their own staff’s prescription re-authorization workload by outsourcing it to digiMedical’s call center, freeing their staff up to focus on patient care.
More Information on Digitally Secure, End-to-End Prescription Handling
digiMedical’s leading edge, digitally secure prescription handling software, which is currently in use in doctors’ offices, clinics, and pharmacies in Naples, Ft. Meyers, and Fort Lauderdale, Florida, and in Dallas, Texas, is now available for implementation nationwide. If you are a doctor or pharmacist interested in learning more about digiMedical’s software, or implementing the Company’s proprietary technology in your office, clinic or pharmacy, please contact the Company at email@example.com or 1-877-450-8181.
To be added to digiMedical’s corporate e-mail list for shareholders and interested investors or to request additional information about the Company, please send an e-mail to firstname.lastname@example.org.
About digiMedical Solutions, Inc.(TM)
digiMedical Solutions, Inc.(TM) (www.digimedical.com) is a pharmacy and medical technology company focused on developing next generation digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that will more closely align the doctor, pharmacist and patient. The Company’s digital prescription handling software captures and transmits prescriptions digitally from the physician’s office to the pharmacy, securely and in compliance with all DEA and HIPAA requirements. The suite of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and digiAccounting.
Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as “Forward-Looking Statements” for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-Looking Statements may be identified by words including “anticipate,”"await,”"envision,”"foresee,”"aim at,”"believe,”"intends,”"estimates” including without limitation, those relating to the company’s future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company’s filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company’s business and results of operations.
Contact: digiMedical Solutions, Inc. Investor Relations email@example.com 214-722-3029 Sales: firstname.lastname@example.org 1-877-450-8181
SOURCE: digiMedical Solutions, Inc.